Syndecan-4 as antithrombin receptor of human neutrophils.
about
Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsisIn vivo anti-HIV activity of the heparin-activated serine protease inhibitor antithrombin III encapsulated in lymph-targeting immunoliposomes.The anti-inflammatory actions of antithrombin--a review.Comparison of mechanisms after post-hoc analyses of the drotrecogin alfa (activated) and antithrombin III trials in severe sepsis.Clinical review: molecular mechanisms underlying the role of antithrombin in sepsis.Effects of anticoagulant strategies on activation of inflammation and coagulation.Heparan sulfate proteoglycans: a GAGgle of skeletal-hematopoietic regulators.Coregulation of fibronectin signaling and matrix contraction by tenascin-C and syndecan-4.Pharmacology and clinical applications of human recombinant antithrombin.Modulation of Tumor Cell Survival, Proliferation, and Differentiation by the Peptide Derived from Tenascin-C: Implication of β1-Integrin Activation.HS3ST1 genotype regulates antithrombin's inflammomodulatory tone and associates with atherosclerosis.Purification of a modified form of bovine antithrombin III as an HIV-1 CD8+ T-cell antiviral factor.Heparan sulfate proteoglycan-dependent neutrophil chemotaxis toward PR-39 cathelicidin.From top to bottom: midkine and pleiotrophin as emerging players in immune regulation.Apoptotic death of hematopoietic tumor cells through potentiated and sustained adhesion to fibronectin via VLA-4Nebulized antithrombin limits bacterial outgrowth and lung injury in Streptococcus pneumoniae pneumonia in ratsHuman Recombinant Antithrombin (ATryn®) Administration Improves Survival and Prevents Intravascular Coagulation After Intraportal Islet Transplantation in a Piglet Model.Attenuation of leukocyte beta 2-integrin expression by antithrombin-III.Antithrombin III pretreatment reduces neutrophil recruitment into the lung in a rat model of abdominal sepsis.Syndecan-4-dependent migration of human eosinophils.Serum Syndecan-4 as a Possible Biomarker in Patients With Acute Pneumonia.
P2860
Q24794692-293BB91D-1F1E-45E2-A753-3EEA083936CCQ34469655-A317296E-DBB1-41A1-8AA5-56F9D1EB496AQ34777707-FBB52744-8A90-43A1-81C4-84467C83AECEQ35794980-AE28CC17-473E-463A-AB71-2EC81F86E4C4Q36423261-A914B9DB-E529-4B06-8739-A07CAF48EAF5Q36842724-468D79AA-DD88-4B2F-8AB1-21A08EA7A8F0Q37117272-C9F6D38C-4366-4CA3-B692-F12FC71E688DQ37657635-A3F2D781-1E13-4CD4-AE67-0B938FDB175EQ37763191-01195728-D385-420E-8298-15E059AAA96AQ37973062-85C048C5-6B00-43CF-A704-DE8B59768C93Q38996741-41BF7182-34B3-4D9B-8323-704EB934E514Q39020001-3AF1A46D-D3D8-4AA5-9C41-9501BD754844Q39070088-FF05C3E1-7A05-420C-83ED-412023816723Q39207404-90FFEECF-31A1-4D3B-8A48-F9FF0BBE6C1CQ39761913-B6AFC78B-5D27-4236-BFF7-AC62D38B4CBDQ42199996-BF693C16-A957-4F6A-AFE9-EA11F5C65E28Q44129052-5ABEE06B-7EF6-4DEE-8580-53AE180B9EEDQ44786505-45A3BA02-0F53-40BB-B022-D154805DE40BQ45269175-16390CBE-1758-4B71-87B2-EEB25492C26DQ47602695-037719DE-4C51-4046-A541-8EEACA0CB72BQ52949851-52FC9F2F-CBC1-4CF6-9E38-CB2DBCB7228E
P2860
Syndecan-4 as antithrombin receptor of human neutrophils.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Syndecan-4 as antithrombin receptor of human neutrophils.
@en
type
label
Syndecan-4 as antithrombin receptor of human neutrophils.
@en
prefLabel
Syndecan-4 as antithrombin receptor of human neutrophils.
@en
P2093
P356
P1476
Syndecan-4 as antithrombin receptor of human neutrophils.
@en
P2093
Dunzendorfer S
Kaneider NC
Wiedermann CJ
P356
10.1006/BBRC.2001.5534
P407
P577
2001-09-01T00:00:00Z